Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DNP has spent the past week doing something the bears will have noticed: the stock climbed 8.6% to PLN 36.51, clearing the analyst consensus price target of PLN 35.14 in the process, with three weeks left before the November 5 earnings print.
The short-side retreat documented last week has continued and, in some respects, accelerated. The ORTEX short score stood at 70.1 on October 2. By October 9 it had edged up to 72.7, before settling back to 71.9 on October 12. That is a modest reversal of the directional easing seen through September, though it remains well below the 74.5 reading of September 16 that marked the recent peak in bearish conviction. Availability has tightened from 207% of short interest at the start of the month to 173% now, its lowest point in three weeks. The 52-week floor of 150%, touched on September 11, still provides a reference: the lending market has loosened materially from that extreme and remains comfortable rather than stressed. Borrowing costs are running at 0.82%, roughly flat on the week and close to a 30-day low. The structural picture is one of easing shorts that have not fully covered, pausing rather than reversing.
The Street is now looking up at a stock that has risen through its own price target. The mean analyst target of PLN 35.14 sat above the October 5 close of PLN 33.66 when the last note was published; DNP has since gained roughly 8.6% to trade above it. The analyst recommendation differential factor score ranks in the 94th percentile, suggesting the consensus has been more constructive than most of the universe. Forward earnings momentum is the strongest read in the factor table, with the 12-month forward EPS year-on-year increase scoring in the 100th percentile. The short score rank, by contrast, sits at just the 5th percentile, meaning significant short interest remains relative to peers. The PE multiple has expanded to 18.8x, up 1.5 points on the week, reflecting the price move. EV/EBITDA has drifted lower to 11.3x over the past 30 days, edging in the opposite direction as enterprise value calculations lag the equity re-rating. The two signals are not contradictory: a re-rating that runs ahead of fundamental upgrades is the typical shape of a stock clearing a price-target ceiling.
Ownership is anchored by founder Tomasz Biernacki at 51.2% of shares, a concentration that limits float and amplifies moves in either direction when institutional flows shift. BlackRock added 1.4 million shares as of September 30, and Goldman Sachs Asset Management added 965,000 shares as of October 1. Baillie Gifford also added 2.2 million shares through June. On the other side, Norges Bank Investment Management trimmed by 5.7 million shares through June. The recent international buying from BlackRock and Goldman is fresh and directionally consistent with the price action.
The recent earnings history adds context to the November 5 date. After the August 20 print, DNP gained 7% on the day and 9% over the following five days. After the May 14 print, the one-day move was 12.6% and the five-day follow-through 10.8%. Both of the last two releases produced material positive reactions. That pattern does not repeat automatically, but it does explain why a short book sitting at 10.5% of free float carries real risk into a print where the company has consistently surprised to the upside.
The question heading into November 5 is whether the price, having cleared the analyst target on the back of short covering and fresh institutional buying, can find new fundamental justification for a higher range, or whether it stalls with the Street needing to revise targets upward before conviction returns.
See the live data behind this article on ORTEX.
Open DNP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
